Using MicroRNA To Identify Triple-Negative Breast Cancer Subtypes
2/11/2013
A new, large-scale study of triple-negative breast cancer shows that small molecules called microRNA can be used to define four subtypes of this aggressive malignancy. The findings, by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
Boosting Body's Natural Tumor-Fighting Protein May Aid Cancer Treatment
2/11/2013
New research from the US suggests it may be possible boost a natural tumor-fighting protein that is already present in the body's immune system to enhance the effectiveness of cancer treatment, especially for advanced cancers that are difficult to treat...
Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood, requiring patients to undergo more repair procedures to the site through which blood is removed and returned, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN)...
Exercise Linked With Reduced Prostate Cancer Risk In Caucasians But Not African Americans
2/11/2013
A new study suggests that exercise may reduce Caucasian men's risk of developing prostate cancer. And among Caucasian men who do have prostate cancer, exercise may reduce their risk of having more serious forms of the disease. Unfortunately, the benefits do not seem to apply to African- American men...
Study Using Cells Forged From Human Skin Shows Promise In Treating MS, Myelin Disorders
2/11/2013
A study out today in the journal Cell Stem Cell shows that human brain cells created by reprogramming skin cells are highly effective in treating myelin disorders, a family of diseases that includes multiple sclerosis and rare childhood disorders called pediatric leukodystrophies...
Pomalyst (pomalidomide) For Advanced Multiple Myeloma Approved By FDA
2/11/2013
Pomalyst (pomalidomide) has been approved by the FDA for the treatment of patients with multiple myeloma whose cancer progressed after being treated with other medications. Pomalyst, which is presented in capsule form, modulates the immune system so that the patient's own body destroys cancerous cells and undermines their growth...
Exercise Linked With Reduced Prostate Cancer Risk In Caucasians But Not African Americans
2/11/2013
A new study suggests that exercise may reduce Caucasian men's risk of developing prostate cancer. And among Caucasian men who do have prostate cancer, exercise may reduce their risk of having more serious forms of the disease. Unfortunately, the benefits do not seem to apply to African- American men...
Pomalyst (pomalidomide) For Advanced Multiple Myeloma Approved By FDA
2/11/2013
Pomalyst (pomalidomide) has been approved by the FDA for the treatment of patients with multiple myeloma whose cancer progressed after being treated with other medications. Pomalyst, which is presented in capsule form, modulates the immune system so that the patient's own body destroys cancerous cells and undermines their growth...
Study Using Cells Forged From Human Skin Shows Promise In Treating MS, Myelin Disorders
2/11/2013
A study out today in the journal Cell Stem Cell shows that human brain cells created by reprogramming skin cells are highly effective in treating myelin disorders, a family of diseases that includes multiple sclerosis and rare childhood disorders called pediatric leukodystrophies...
IBM Supercomputer "Watson" To Help In Cancer Treatment
2/10/2013
Oncologists hope that IBM's Watson supercomputer can help them improve the speed and efficacy of cancer treatments, IBM announced. Two years ago, "Watson" beat all-time Jeopardy! champions. Dr...